Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-583-1 | CAS number: 108-44-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline 422 study and GLP
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD TG 422
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- m-toluidine
- EC Number:
- 203-583-1
- EC Name:
- m-toluidine
- Cas Number:
- 108-44-1
- Molecular formula:
- C7H9N
- IUPAC Name:
- 3-methylaniline
- Details on test material:
- purity : 99 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Details on test animals or test system and environmental conditions:
- Acclimatisation: 5 days
Temperature of the animal room: 22 °C
Relative humidity: 30-70 %
Lighting 12 hours light 12 hours dark
Food ad libitum,
Water ad libitum
Pregnant females should be caged individually
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- Dosing of both sexes should begin 2 weeks prior to mating , continued through mating period
Males: dosing continued up to the day when femalesare killed
Females. dosing continued throughout pregnancy and up to day 4 of lactation - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- method not mentioned
- Details on mating procedure:
- One female to one male until pregnancy occurs; day 0 of pregnancy is defined as the day sperm is found.
- Duration of treatment / exposure:
- Males 42 days;
Females: from day 14 prior to mating to day 3 of lactation ( ca.42 days). - Frequency of treatment:
- daily
- Duration of test:
- Males 42 days; females: from day 14 prior to mating to day 3 of lactation ( ca.42 days).
- No. of animals per sex per dose:
- 13
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- As requested by OECD TG 422
Examinations
- Maternal examinations:
- At least once per day:
--behavioual changes , signs of difficult or prolonged parturition, mortality and all signs of toxicity
--cage side observations: changes in skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system function
--food cinsumption, males and females should be weighed
--duration of gestation, examination of the litter as soon as possible: number and sex of pups, stillbirth, live birth, pup weight, and the presence of ggross anomalies
clinical examinations: hematology, clinical chemistry, urinalysis
pathology: gross necropsy, histopathology - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of resorptions: Yes - Fetal examinations:
- - External examinations: Yes:
- Statistics:
- yes, but method not mentioned
- Indices:
- Copulation index
Fertility index
Gestation index
Implantation index
Delivery index
Birth index
Viability index - Historical control data:
- No data
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects: yes
Details on maternal toxic effects:
no compound related effects adverse effects were detected with regared to the mating performance of any of the dosed rats. However, 2/10 pregnant females receiving 100 mg/kg bw/day and all the 11 females receiving 300 mg/kg bw/day showed toatal implantation losses in utero
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 30 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: maternal toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- 100 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: developmental toxicity
- Dose descriptor:
- LOAEL
- Effect level:
- 30 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: other:
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects: no effects
Details on embryotoxic / teratogenic effects:
No significant differences in the pup viability, pup weights and incidence of morphological abnormalities of pups were apparent in the groups given 100 mg/kg bw/day or less when compared to controls.
Effect levels (fetuses)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 100 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: developmental toxicity
- Dose descriptor:
- LOAEL
- Effect level:
- 30 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: other
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Applicant's summary and conclusion
- Executive summary:
In the available OECD combined repeated dose and reproductive /developmental toxicity screening study according to OECD TG 422 and GLP male and female rats received doses of 0, 30, 100 and 300 mg/kg bw/day 14 days before mating to 14 days after mating in males and fron 14 days before mating to day 3 of lactation in females (MHLW 1995).
The LOAEL (general toxicity) is 30 mg/kg bw/day based on deposit pigmentation and extramedullary hematopoiesis in all examined animals (UNEP 2003).
No compound-related adverse effects were detected with regard to the mating performances at any dose level. However, 2/10 pregnant females receiving 100 mg/kg bw/day and all eleven receiving 300 mg/kg bw/day showed total implant losses in utero. Therefore the NOAEL for reproductive toxicity is considered to be 30 mg/kg bw/day (UNEP 2003).
2/11 pregnant females receiving 30 mg/kg bw/day and 3/10 receiving 100 mg/kg bw/day did not show nursing activity obviously and 11 or more than half number of their pups died after birth, while all live offsprings of other dams in 30 and 100 mg/kg groups had normally developed up to 4 days. Therefore this death of pups is considered as a result of maternal toxicity , probably due to anemia. Furthermore, change of pup weights and incidence of morphologic abnormalities of pups were not significant in 30 and 100 mg/kg . The NOAEL for developmental toxicity is considered to be 100 mg/kg bw/day (UNEP 2003).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.